Guidelines – SGH-SSH

SSH GUIDELINES

SSH guidelines policy update 01.05.2021

Please click on the respective title to see the guidelines

1) Clinical hematology: Benign disorders

2) Clinical hematology: Myeloid malignancies

3) Clinical hematology: Lymphoid malignancies and plasma cell disorders

4) Transplantation and cellular therapy

5) Laboratory diagnosis

6) Thrombosis and hemostasis

Recommendations for the use of andexanet alfa in the management of bleeding in patients on oral factor Xa inhibitors in Switzerland
How to diagnose and treat acquired hemophilia: a consensus statement of the Working Party on Hemostasis of the SSH
Proposals for thromboprophylaxis and monitoring in hospitalizedpatients with COVID-19
Recommendations on the use of anticoagulants for the treatment of patients with heparin-induced thrombocytopenia in Switzerland
Management of bleeding events and invasive procedures in patients with haemophilia A without inhibitors treated with emicizumab

7) Transfusion medicine

8) General skills

9) Radiation protection

10) Nuclear accidents

LINKS

Onkopedia: https://www.onkopedia.com/de/onkopedia/guidelines
EHA: https://ehaweb.org/covid-19/